Epstein-Barr virus and Burkitt’s lymphoma. Associations in Iraqi Kurdistan and twenty-two countries assessed in the International Incidence of Childhood Cancer

Wright DH. What is Burkitt’s lymphoma and when is it endemic. Blood. 1999;93:758.

CAS  PubMed  Article  Google Scholar 

Brady G, MacArthur GJ, Farrell PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol. 2007;60:1397–402.

CAS  PubMed  PubMed Central  Google Scholar 

Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017;372:20160271.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Mbulaiteye SM, Anderson WF, Bahtia K, Rosenberg PS, Linet MS, Devesa SS. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973–2005. Int J Cancer. 2010;126:1732–9.

CAS  PubMed  PubMed Central  Google Scholar 

Linch DC. Burkitt lymphoma in adults. Br J Haematol. 2012;156:693–703.

CAS  PubMed  Article  Google Scholar 

Hammerl L, Colombet M, Rochfort R, Ogwang DM, Parkin DM. The burden of Burkitt lymphoma in Africa. Infect Agent Cancer. 2019;14:17.

PubMed  PubMed Central  Article  Google Scholar 

Musekwa E, Chapanduka ZC, Bassa F, Kruger M. An 8-year retrospective study of adult and pediatric Burkitt’s lymphoma at Tygerberg Hospital, South Africa. S Afr J Oncol. 2020;4: a93.

Article  Google Scholar 

Anwar N, Kingma DW, Bloch AR, Mourad M, Raffeld M, Franklin J, Magrath I, el Bolkainy N, Jaffe ES. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt’s lymphoma from Egypt. Cancer. 1995;76:1245–52.

CAS  PubMed  Article  Google Scholar 

Yaqo RT, Jalal SD, Ghafour KJ, Hassan HA, Hughson MD. Non-Hodgkin lymphoma in the Middle East is characterized by low incidence rates with advancing age. J Glob Oncol. 2019;5:1–10.

PubMed  Article  Google Scholar 

Uccini S, Al-Jadiri MF, Cippitelli C, Talerico C, Scarpino S, Al-Darraji AF, Al-Badri SAF, Alsaadawi AR, Al-Hadad SA, Ruco L. Burkitt lymphoma in Iraqi children: a distinctive form of sporadic disease with high incidence of EBV+ cases and more frequent expression of MUM1/IRF4 in cases with head and neck presentation. Pediatr Blood Cancer. 2018;65: e27399.

PubMed  Article  CAS  Google Scholar 

Satou A, Asano N, Nakazawa A, Osumi T, Tsurusawa M, Ishiguro A, Elsayed AA, Nakamura N, Ohshima K, Kinoshita T, Nakamura S. Epstein-Barr virus (EBV)-positive sporadic Burkitt lymphoma. An age-related lymphoproliferative disorder? Am J Surg Pathol. 2015;39:227–35.

PubMed  Article  Google Scholar 

Winter JR, Jackson C, Lewis JE, Taylor GS, Thomas OG, Stagg HR. Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: a systematic review of the literature. J Glob Health. 2020;10: 010404.

PubMed  PubMed Central  Article  Google Scholar 

Kerr JR. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol. 2019;72:651–8.

CAS  PubMed  Article  Google Scholar 

Dowd JB, Palermo T, Brite J, McDade TW, Aletto A. Seroprevalence of Epstein-Barr virus infection in US children ages 6–19, 2003–2010. Plos One. 2013;8: e64921.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Smatti MK, Yassine HM, AbuOdeh R, AlMarawani A, Taleb SA, Althani AA, Nasrallah GK. Prevalence and molecular profiling of Epstein-Barr virus (EBV) among healthy blood donors from different nationalities in Qatar. Plos One. 2017;12: e0189033.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Farid E, Al-Biltagi M. Trend and seroprevalence of Epstein-Barr virus in Bahrain; 2001–2015. East Mediterr Health J. 2017;23:821–9.

Article  Google Scholar 

Sharifipour S, Davoodi Rad K. Seroprevalence of Epstein-Barr virus among children and adults in Tehran Iran. New Microbes New Infect. 2020;34: 100641.

CAS  PubMed  PubMed Central  Article  Google Scholar 

International Incidence of Childhood Cancer. Volume III. International Agency for Research on Cancer. World Health Organization; 2021 https://iicc.iarc.fr/results/, Last accessed 11/14/2021.

Ladjadj Y, Philip T, Lenoir GM, Tazerout FZ, Bendisari K, Boukheloua R, Biron P, Brunat-Mentigny M, Aboulola M. Abdominal Burkitt-type lymphoma in Algeria. Br J Cancer. 1984;49:503–12.

CAS  PubMed  PubMed Central  Article  Google Scholar 

El-Amrani-Joutey M, Jiminez-Garcia R, Linares-Garcia-Valdecasas R, Palomar-Gallego MA, Jimenez-Trujillo I, Lopez-de-Andres A, Vasquez-Vasquez L. Infection by Epstein-Barr virus in Fez (Morrocco). Prevalence and predictors of positivity in nasophayngeal cancer. J Infect Pub Health. 2018;11:807–11.

Article  Google Scholar 

Peylan-Ramu N, Diment J, Krichevsky S, Ben-Yehuda D, Bhatia K, Magrath IT. Expression of EBV encoded nuclear small non-polyadenylated mRNA (EBER) molecules in 32 cases of childhood Burkitt’s lymphoma from Isreal. Leuk Lymphoma. 2001;40:405–11.

CAS  PubMed  Article  Google Scholar 

Levine H, Balicer RD, Rozhavski V, Halperin T, Shreberk M, Davidovich N, Huerta-Hartal M, Ankol OE. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults. Ann Epidemiol. 2012;22:783–8.

PubMed  Article  Google Scholar 

Cavdar AO, Yavuz G, Babacan E, Gozdasoglu S, Unal E, Ertem U, Pamir A, Yucesan S, Gokcora H, Uluoglu O, Ikinciogullari A. Burkitt’s lymphoma in Turkish children: clinical, viral (EBV) and molecular studies. Leuk Lymphoma. 1994;14:323–30.

CAS  PubMed  Article  Google Scholar 

Walusansa V, Okuku F, Orem J. Burkitt lymphoma in Uganda, the legacy of Denis Burkitt and an update on the disease status. Br J Haematol. 2012;156:757–60.

PubMed  Article  Google Scholar 

Enow-Orock GE, Tchatchoua B, Koki NP. Burkitt’s lymphoma in Cameroon: A review of 300 cases in two referral Health facilities in Yaounde. Afr J Pathol Microbiol. 2013;2:235615.

Article  Google Scholar 

Mabilangan C, Burton C, O’Brien S, Plitt S, Eurich D, Preiksaitis J. Using blood donors and solid organ transplant donors and recipients to estimate the seroprevalence of cytomegalovirus and Epstein-Barr virus in Canada: a cross-sectional study. J Assoc Medical Microbiol Infect Disease Canada. 2020;5:158–76.

Google Scholar 

Roy SF, Ghazawi FM, Le M, Lagace F, Roy CF, Rahme E, Savin E, Zubarev A, Sasseville D, Popradi G, Litvinov IV. Epidemiology of adult and pediatric Burkitt lymphoma in Canada: sequelae of the HIV epidemic. Curr Oncol. 2020;27:83–9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN, Mbulaiteye SM. Risk factors for Burkitt’s lymphoma: a nested case-control study in the UK clinical practice research datalink. Brit J Haematol. 2018;181:505–14.

Article  Google Scholar 

Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middledorp J, Giovannoni G, Dobson R. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. BMC Public Health. 2020;20:912.

PubMed  PubMed Central  Article  Google Scholar 

Abrahamyan S, Eberspacher B, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Schroeder C, Gruter T, Tackenberg B, Paul F, Then-Bergh F, Kumpfel T, Weber F, Stangel M, Bayas A, Wildemann B, Heesen C, Zetti U, Warnke C, Antony G, Hessler N, Wiendl H, Bittner S, Hemmer B, Gold R, Salmen A, Ruprecht K, German Competence Network Multiple Sclerosis (KKNMS). Complete Epstein-virus seropositivity in a large cohort of patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2020;91:681–6.

PubMed  Article  Google Scholar 

Fourcade G, Germi R, Guerber F, Lupo J, Baccard M, Seigneurin A, Semenova T, Morand P, Epaulard O. Evolution of EBV seroprevalence and primary infection in a French hospital and a city laboratory network, 2000–2016. Plos One. 2017;12:e0175574.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Pannone G, Zamparse R, Pace M, Pedicillo MC, Cagiano S, Somma P, Errico ME, Donofrio V, Franco R, De Chiara A, Aquino G, Bucci P, Bucci E, Santoro A, Bufo P. The role of EBV in the pathogenesis of Burkitt’s lymphoma: an Italian hospital based survey. Infect Agent Cancer. 2014;9:34.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Franci G, Crudele V, Della Rocca MT, Melardo C, Chianese A, Finamore E, Bencivenga F, Astori R, Vitiello M, Galdiero E, Galdiero M. Epstien-Barr virus seroprvalence at the University Hospital Luigi Vanvitelli of Naples from 2007–2017. Intervirology. 2019;62:15–22.

PubMed  Article  Google Scholar 

Pariente M, Bartolome J, Lorente S, Crespo MD. Distribucion por edad de los patrones serologicos de infeccion por el virus de Epstein Barr: revision de resultados de un laboratorio de diagnostico. Enferm Infecc Microbiol Clin. 2007;25:108–10.

PubMed  Article  Google Scholar 

Takeuchi K, Tanaka-Taya K, Kazuyama Y, Ito YM, Hashimoto S, Fukayama M, Mori S. Prevalence of Epstein-Barr virus in Japan: Trends and future prediction. Pathol Int. 2006;56:112–6.

PubMed  Article  Google Scholar 

Satou A, Asano N, Kato S, Elsayed AM, Nakamura N, Miyoshi H, Ohshima K, Nakamura S. Prognostic impact of MUM1/IRF4 expression in Burkitt lymphoma (BL). A reappraisal of 88 BL patients in Japan. Am J Surg Pathol. 2017;41:389–95.

PubMed  Article  Google Scholar 

Sim J, Takayama T, Cho J, Kim SJ, Kim WS, Ree HJ, Ko HY. Changing trends in lymphoid neoplasms in South Korea: analysis of 8615 cases from a single institution, 1997–2016: an observational study. Medicine. 2019;98: e17641.

PubMed  PubMed Central  Article  Google Scholar 

Kim DH, Ko YH, Suh Y, Koo HH, Huh JR, Lee WK. Characteristics of Epstein-Barr virus-associated childhood non-Hodgkin’s lymphoma in the Republic of Korea. Virchows Arch. 2005;447:593–6.

PubMed  Article  Google Scholar 

Xiong G, Zhang B, Huang M, Zhou H, Chen L, Fen Q, Luo X, Lin H, Zeng Y. Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence. Plos One. 2014;9: e99857.

PubMed  PubMed Central  Article 

留言 (0)

沒有登入
gif